News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Valeant Pharmaceuticals International
NEWS
IN THE PRESS
NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Policy
Valeant Stock Falls on Default Fears, U.S. Rep. Criticizes Company Over Philidor
April 12, 2016
·
3 min read
Deals
Allergan Chief Brent Saunders On Failed Pfizer Deal And Why He’s Not Like Valeant
April 8, 2016
·
1 min read
Deals
Valeant’s Ackman Says Company Will Not Sell Bausch & Lomb
April 8, 2016
·
3 min read
Business
Ackman Says New Valeant CEO Will be Named Within Weeks
April 7, 2016
·
3 min read
Job Trends
Sprout Team Withers as Valeant Terminates 140 Sales Contractors for the Female Libido Drug
April 5, 2016
·
3 min read
Deals
As Flailing Valeant Pushes Back Earnings Deadlines, Bausch & Lomb Sale Potentially on the Table
March 30, 2016
·
3 min read
Policy
FDA’s Big Task: Stop The Next Martin Shkreli and Valeant
March 28, 2016
·
4 min read
Business
How Pearson Should Manage His Remaining Time As CEO Of Valeant
March 23, 2016
·
1 min read
Business
Valeant Hunts for a New CEO, Blames Former CFO Schiller for Recent Financial Misstatements
March 21, 2016
·
3 min read
IN THE PRESS
Policy
Valeant is Sued Over Philidor Ties, Alleged Racketeering
August 30, 2016
·
1 min read
Business
Embattled Valeant Poaches New CFO From Zoetis
August 22, 2016
·
5 min read
Policy
Valeant Faces New Fraud Lawsuit Filed By Former Investor
August 19, 2016
·
1 min read
Valeant Receives Lender Consent For Credit Facility Amendment
August 18, 2016
·
2 min read
Policy
Valeant Comments On SDNY Investigation
August 11, 2016
·
1 min read
Policy
Valeant Plunges Some More After Report of Criminal Investigation for Defrauding Insurers
August 11, 2016
·
1 min read
Deals
Valeant Receiving Interest for Core Assets, Though the Company is Not Actively Shopping Them
August 10, 2016
·
1 min read
Valeant Announces Significant Support For Education And Research Regarding Wilson Disease
August 9, 2016
·
3 min read
Valeant Announces Relaunch Of Generic Ofloxacin Otic Solution
August 9, 2016
·
4 min read
Deals
As Debt Repayments Loom, Valeant Divests Ruconest Rights to Pharming Group for $125 Million
August 9, 2016
·
15 min read
